PMA device
Vascade Vascular Closure System (VCS)
Cardiva Medical, Inc. · Device, Hemostasis, Vascular (MGB, Class III) · First FDA decision Jan 31, 2013, newest Mar 1, 2023Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
7
Naming "Vascade"
MAUDE reports
444
Brand "Vascade", since 2015
PubMed studies
25
Mentioning "Vascade"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vascade Vascular Closure System (VCS)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Vascade Vascular Closure System (VCS)PMA supplement
P120016-S029 · Decided Mar 1, 2023 · 180 days after receipt · Normal 180 Day Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Vascade", any status and sponsor, newest update first.
- The AMBULATE EXPAND Trial: VASCADE MVP XL for Femoral Venous Access Sites, 16-17F ODPivotal-lookingCompleted
Haemonetics CorporationPublic (HAE)
NCT06615154 · 85 participants · Start Feb 28, 2025 · Primary completion Aug 18, 2025
Device: VASCADE MVP XL (800-1014XL) · For: Surgical Wound; Vascular Access
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vascade", and for the whole product code for context.
This brand
444 reports: 119 malfunction, 306 injury, 18 death
Whole product code MGB
93,533 reports: 17,154 malfunction, 76,023 injury, 315 death
Newest reports for this brand
3011469355-2026-00051 · Received Oct 20, 2026 · Event dated Sep 25, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Abscess
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vascade"[tiab]. The summary above synthesizes these.
- Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial.
Natale A, Mohanty S, Liu PY, et al. · JACC Clin Electrophysiol · 2020Multicenter Study, Randomized Controlled Trial
- Closure of mid-bore venotomies with VASCADE VCD after right and left heart catheterization.
Hmoud H, Sturla M, Delucia L, et al. · Catheter Cardiovasc Interv · 2019Observational Study
- Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry.
Eldadah ZA, Al-Ahmad A, Bunch TJ, et al. · J Cardiovasc Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Real-world VASCADE closure device versus manual compression use and outcomes in patients with severe common femoral artery disease.
Nagpal S, Scierka LE, Castro-Dominguez Y, et al. · Catheter Cardiovasc Interv · 2022
- Efficacy and safety of the VASCADE® MVP venous vascular closure device in patients undergoing percutaneous left atrial appendage occlusion with WATCHMAN.
Golzarian H, Graebel KT, Bailey R, et al. · Catheter Cardiovasc Interv · 2024Comparative Study
- VASCADE closure device use in severe common femoral artery disease.
Ijaz SH, Levy MS · Catheter Cardiovasc Interv · 2022Comment
- Venous Access Site Closures Using the VASCADE Vascular Closure System.
Dou E, Winokur RS, Sista AK · J Vasc Interv Radiol · 2016
- Contemporary post-marketing adverse events and modes of failure related to VASCADE Vascular Closure System: The utility of the MAUDE database.
Case BC, Kumar S, Medranda GA, et al. · Catheter Cardiovasc Interv · 2022
- A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients.
Hermiller JB, Leimbach W, Gammon R, et al. · J Invasive Cardiol · 2015Multicenter Study, Randomized Controlled Trial
- Safety and efficacy of arterial closure devices in an office-based angiosuite.
Dham S, Ahn S · J Vasc Surg · 2025Comparative Study, Research Support, Non-U.S. Gov't
- Hepatic and splenic venous access tract closure using the VASCADE vascular closure system following percutaneous intervention in patients with CHD.
Eilers LF, Bansal M, Khan A, et al. · Cardiol Young · 2024
- Femoral vein occlusion after VASCADE MVP resolved without surgery: a case report.
Honda M, Takigawa M, Yonetsu T, et al. · Eur Heart J Case Rep · 2025Case Reports
Other devices of this type
Also filed under product code MGB.
- Angio-Seal Vascular Closure DeviceTerumo Medical Corporation · PMA 2013
- Perclose ProGlide® Suture-Mediated Closure SystemAbbott Vascular, Inc. · PMA 2025
- StarClose SE® Vascular Surgical SystemAbbott Vascular Devices · PMA 2025
- Mynx Vascular Closure DeviceCordis US Corporation · PMA 2013
- MANTA Vascular Closure DeviceTeleflex Medical, LLC · PMA 2024
- MynxGrip and Mynx Ace Vascular Closure DeviceCordis US Corporation · PMA 2018
- Vascular Solutions Duett Sealing DeviceVascular Solutions, Inc. · PMA 2010
- Angio-Seal Hemostatic Puncture Closure DeviceTerumo Medical Corporation · PMA 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.